<?xml version="1.0" encoding="UTF-8"?>
<p id="Par63">Viruses induce an explosion of inflammatory cytokines and reactive oxygen species, and melatonin, a well-known anti-inflammatory and anti-oxidative molecule, protects against acute respiratory distress syndrome caused by viral and other pathogens. Melatonin is effective in critical care patients by reducing vessel permeability, anxiety, sedation use, and improving sleeping quality, which might also be beneficial for COVID-19 patients. In addition, melatonin could be an adjuvant to prevent pulmonary fibrosis [
 <xref ref-type="bibr" rid="CR108">108</xref>]. Notably, melatonin has a high safety profile [
 <xref ref-type="bibr" rid="CR109">109</xref>]. There are no reports on the use of melatonin in COVID-19 to date [
 <xref ref-type="bibr" rid="CR108">108</xref>].
</p>
